Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
crownbio.com

See what CB Insights has to offer

Founded Year

2006

Stage

Acquired | Acquired

Total Raised

$74.35M

Valuation

$0000 

About Crown Bioscience International

Crown Bioscience International is a drug discovery and development service company providing translational platforms and drug discovery solutions for its biotech and pharmaceutical partners in the dedicated therapeutic areas: oncology and metabolic disease. The company's HuPrime, HuKemia, HuBase, HuMark, HuTrial and HuSignature platforms enable unique lead optimization and translational strategies to deliver superior clinical candidates.

Crown Bioscience International Headquarter Location

16550 West Bernardo Drive Building 5, Suite 525

San Diego, California, 92127,

United States

+1 858 622 2900

Latest Crown Bioscience International News

Crown Bioscience Invests in Commercial Leadership

Jul 20, 2021

New Vice President to lead North America and Europe Business Development July 20, 2021 08:30 AM Eastern Daylight Time SAN DIEGO--( BUSINESS WIRE )--Crown Bioscience, a JSR Life Sciences company, today announces the appointment of Alex Slater as Vice President of Business Development, North America and Europe. In this role, Mr Slater will be responsible for the continued growth within the Company’s existing services portfolio and for setting the foundation for the expansion of new services. The investment in additional leadership within CrownBio’s commercial and strategic development division reflects the increasing breadth and scientific depth of the company's offerings, and an appreciation of the need for tailored solutions at both an account and territory level. The new position will complement recent expansions in CrownBio’s Marketing, Product Management and Scientific Engagement departments, and is part of the company’s broader commitment to ensure that their customers' experience is industry-leading. Commenting on the appointment, Mike Prosser, Senior Vice President, Commercial and Strategic Development, said, “I am delighted to welcome Alex to the team, and to fill another crucial role for the company, during an exciting phase of CrownBio’s growth. Alex’s extensive leadership experience in the CRO industry, encompassing multiple phases of drug discovery and development, will be invaluable to us as we evolve our teams in line with market opportunity.” Mr. Slater joins CrownBio from Biocellvia, where he was VP of the business development function. In previous roles, he has served as Global VP for Business Development at Eurofins and held multiple sales leadership positions at Covance/LabCorp. “During my interview process I was impressed by the strength of the leadership team at CrownBio, their commitment to innovation and the value they place in their customers’ experience,” commented Alex. “Further, the business development team already in place at CrownBio is highly motivated and professional and in my capacity as VP of Business Development I look forward to working with them to accelerate the organization’s future expansion.” About Crown Bioscience Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology, immuno-oncology and inflammatory disorders. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. Find out more at: http://www.CrownBio.com Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Crown Bioscience International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Crown Bioscience International is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer

4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

R

Regenerative Medicine

1,708 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Crown Bioscience International Patents

Crown Bioscience International has filed 5 patents.

The 3 most popular patent topics include:

  • Bones of the head and neck
  • Dietary supplements
  • Fluid dynamics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/31/2013

3/20/2018

Experimental cancer drugs, Lung cancer, Monoclonal antibodies for tumors, Monoclonal antibodies, Fluoroarenes

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/31/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/20/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Experimental cancer drugs, Lung cancer, Monoclonal antibodies for tumors, Monoclonal antibodies, Fluoroarenes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.